|
LOC493754 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.555800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.949580E-02 |
| Normal-vs-Stage2 |
1.775220E-01 |
| Normal-vs-Stage3 |
1.602900E-03 |
| Normal-vs-Stage4 |
2.132200E-02 |
| Stage1-vs-Stage2 |
7.442200E-01 |
| Stage1-vs-Stage3 |
1.444240E-01 |
| Stage1-vs-Stage4 |
5.497400E-01 |
| Stage2-vs-Stage3 |
2.011400E-01 |
| Stage2-vs-Stage4 |
4.547600E-01 |
| Stage3-vs-Stage4 |
6.298400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.901200E-03 |
| Normal-vs-AfricanAmerican |
2.917600E-01 |
| Normal-vs-Asian |
1.146010E-02 |
| Caucasian-vs-AfricanAmerican |
5.578700E-03 |
| Caucasian-vs-Asian |
6.638600E-01 |
| AfricanAmerican-vs-Asian |
6.759200E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.329680E-02 |
| Normal-vs-Female |
8.196200E-03 |
| Male-vs-Female |
7.665600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.518000E-02 |
| Normal-vs-Age(41-60Yrs) |
5.317900E-03 |
| Normal-vs-Age(61-80Yrs) |
7.056800E-03 |
| Normal-vs-Age(81-100Yrs) |
2.477800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.902010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.735030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.378200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.841400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.846180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.840400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.36249999999916E-05 |
| Classical-VS-Follicular |
1.299030E-01 |
| Classical-VS-Other |
8.353800E-01 |
| Classical-VS-Normal |
1.215240E-01 |
| Tall-VS-Follicular |
1.398400E-02 |
| Tall-VS-Other |
3.109800E-02 |
| Tall-VS-Normal |
2.88510000001629E-06 |
| Follicular-VS-Other |
5.375200E-01 |
| Follicular-VS-Normal |
1.432250E-02 |
| Other-VS-Normal |
6.431600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.158800E-03 |
| Normal-vs-N1 |
7.454100E-02 |
| N0-vs-N1 |
5.860200E-01 |
|
|
